REFERENCES
1. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax
1971;26(3):240-248.
2. Giroud JM, Jacobs JP. Fontan’s operation: evolution from a procedure
to a process. Cardiol Young 2006;16 Suppl 1:67-71.
3. de Leval MT, Kilner P, Gewillig M et al. Total cavopulmonary
connection: a logical alternative to atriopulmonary connection for
complex Fontan operations. Experimental studies and early clinical
experience. J Thorac Cardiovasc Surg 1988;96:682-695.
4. Marceletti C, Corno A, Giannico S et al. Inferior vena cava-pulmonary
artery extracardiac conduit. A new form of right heart bypass. J Thorac
Cardiovasc Surg 1990:100:228-232.
5. Bridges ND, Lock JE, Castenada AR. Baffle fenestration with
subsequent transcatheter closure. Modification of the Fontan operation
for patients at increased risk. Circulation 1990;82:1681-1689.
6. van Doorn CA, de Leval MR. The Fontan operation in clinical practice:
indications and controversies. Nat Clin Pract Cardiovasc Med
2005;2(3):116-117.
7. Choussat A, Fontan F, Besse P. Selection criteria for the Fontan
procedure. In: Anderson RH, Shinebourne (editors) Pediatric Cardiology.
Churchill Livingstone, Edinburgh, Scotland (1977) pp:559-566.
8. Driscoll DJ. Long term results of the Fontan operation. Pediatr
Cardiol 28:438-442.
9. Stern HJ. Fontan ‘Ten Commandments’ revisited and revised.
Pediatr Cardiol 2010;31(8):1131-1134.
10. Starr I, Jeffers WA, Meade RH Jr. The absence of conspicuous
increments of venous pressure after severe damage to the right ventricle
of the dog, with a discussion of the relation between clinical
congestive failure and heart disease. Am Heart J 1943;26:291-301.
11. Jonas RA. The intra/extracardiac conduit fenestrated Fontan. Semin
Thorac Cardiovasc Surg Pediatr Card Surg Annu 2011;14(1):11-18.
12. Jonas RA. Fontan or septation: When I abandon septation in complex
lesions with two ventricles. Semin Thorac Cardiovasc Surg Pediatr Card
Surg Annu 2009:94-98.
13. Jacobs ML, Mayer JE. Congenital heart surgery nomenclature and
database project: single ventricle. Ann Thorac Surg 2000;69(4
Suppl)S197-204.
14. Hosein RBM, Clarke AJB, Mc Guirk SP et al. Factors influencing early
and late outcome following the Fontan procedure in the current era. The
’Two Commandments’? Eur J Cardiothorac Surg 2007;31(3):344-352.
15. Burkhart HM. Closing in on the perfect Fontan. J Thorac Cardiovasc
Surg 2014;148(6):2525.
16. Gewillig M, Brown SC, Eyskens B et al. The Fontan circulation: who
controls cardiac output? Interact Cardiovasc Thorac Surg
2010;10(3):428-433.
17. Saouti N, Westerhof N, Postmus PE, Vonk-Noordegraaf A. The arterial
load in pulmonary hypertension. Eur Respir Rev 2010;19(117):197-203.
18. Alsaied T, Bokma JP, Engel ME et al. Predicting long-term mortality
after Fontan procedures: A risk score based on 6707 patients from 28
studies. Congenit Heart Dis 2017;12(4):393:398.
19. Kim SJ, Kim WH, Lim HG, Lee JY. Outcome of 200 patients after an
extracardiac Fontan procedure. J Thorac Cardiovasc Surg
2008;136(1):108-116.
20. Burkhart HM, Dearani JA, Mair DD, Warnes CA et al. The modified
Fontan procedure: early and late results in 132 adult patients. J Thorac
Cardiovasc Surg 2003;125(6):1252-1259.
21. Pundi KN, Johnson JN, Dearani JA, Pundi KN et al. 40-Year follow-up
after the Fontan operation: Long-term outcomes of 1,052 patients. J Am
Coll Cardiol 2015;66(15):1700-1710.
22. Tran S, Sullivan PM, Cleveland J, Kumar SR, Takao C. Elevated
Pulmonary artery pressure, not Pulmonary vascular resistance is an
independent predictor of short-term morbidity following bidirectional
cavopulmonary connection. Pediatr Cardiol. 2018;39(8):1572-1580.
23. Itatani K, Miyaji K, Nakahata Y et al. The lower limit of the
pulmonary artery index for the extracardiac Fontan circulation. J Thorac
Cardiovasc Surg. 2011;142(1):127-135.
24. Fontan F, Fernandez G, Costa F et al. The size of
the pulmonary arteries and the results of the Fontan operation. J Thorac
Cardiovasc Surg. 1989;98(5 Pt 1):711-719; discussion 719-724.
25. Henaine R, Vergnat M, Bacha EA et al. Effects of lack of pulsatility
on pulmonary endothelial function in the Fontan circulation. J Thorac
Cardiovasc Surg 2013;146(3):522-529.
26. Gewillig M, Brown SC, Heying R et al. Volume load paradox while
preparing for the Fontan: not too much for the ventricle, not too little
for the lungs. Interact Cardiovasc Thorac Surg 2010;10(2):262-265.
27. Milnor WR, Bergel DH, Bargainer JD. Hydraulic power associated with
pulmonary blood flow and its relation to heart rate. Circ Res.
1966;19(3):467-480.
28. Jolley M, Colan SD, Rhodes J, DiNardo J.
Fontan physiology revisited. J.Anesth Analg. 2015;121(1):172-182.
29. Wang W, Hu X, Liao W et al. The efficacy and safety
of pulmonary vasodilators in patients with Fontan circulation: a
meta-analysis of randomized controlled trials.
Circ. 2019;9(1):2045894018790450.
30. Mascio CE, Wayment M, Colaizy TT et al. The modified Fontan
procedure and prolonged pleural effusions. Am Surg 2009;75(2):175-177.
31. Yun TJ, Im YM, Jung SH et al. Pulmonary vascular compliance and
pleural effusion duration after the Fontan procedure. Int J Cardiol.
2009;133(1):55-61.
32. Van Arsdell GS, McCrindle BW, Einarson KD et al. Interventions
associated with minimal Fontan mortality. Ann Thorac Surg
2000;70(2):568-574.
33. François K, Bove T, Groote KD et al. Pleural effusions, water
balance mediators and the influence of lisinopril after completion
Fontan procedures. Eur J Cardiothorac Surg 2009;36(1):57-62.
34. Rothman A, Mayer JE, Freed MD. Treatment of chronic pleural
effusions after the Fontan procedure with prednisone. Am J Cardiol
1987;60(4):408-409.
35. Tansel T, Sayin OA, Ugurlucan M, Dayioglu E, Onursal E. Successful
bleomycin pleurodesis in a patient with prolonged pleural effusion after
extracardiac Fontan procedure. J Card Surg 2006;21(6):585-586.
36. Kiziltepe U, Eyileten Z, Uysalel A, Akalin H. Prolonged pleural
effusion following Fontan operation: effective pleurodesis with talc
slurry. Int J Cardiol 2002;85(2-3):297-299.
37. Lemler MS, Scott WA, Leonard SR, Stromberg D, Ramaciotti C.
Fenestration improves clinical outcome of the Fontan procedure: a
prospective, randomized study. Circulation 2002;105(2):207-212.
38. Bouhout I, Walid BA, Khalaf D, Raboisson MJ, Poirier N. Effect of
Fenestration on Fontan Procedure Outcomes: A Meta-Analysis and Review.
Ann Thorac Surg 2020;109(5):1467-1474.
39. Cai J, Zhaokang S, Zhenying S et al. Nitric oxide and milrinone:
combined effect on pulmonary circulation after Fontan-type procedure: a
prospective, randomized study. Ann Thorac Surg 2008;86(3):882-888.
40. Backer CL. An aspirin a day. J Am Coll Cardiol 2013;61(3):354-355.
41. Jacobs ML, Pourmoghadam KK, Geary EM et al. Fontan’s operation: is
aspirin enough? Is coumadin too much? Ann Thorac Surg 2002;73(1):64-68.
42. Li D, Li M, Zhou X, An Q. Comparison of the fenestrated and
non-fenestrated Fontan procedures: A meta-analysis. Medicine (Baltimore)
2019;98(29):e16554.
43. Airan B, Sharma R, Choudhary SK et al. Univentricular repair: is
routine fenestration justified? Ann Thorac Surg 2000;69(6):1900-1906.
44. Hopkins RA, Armstrong BE, Serwer GA, Peterson RJ, Oldham HN.
Physiological rationale for a bidirectional cavopulmonary shunt. A
versatile complement to the Fontan principle. J Thorac Cardiovasc Surg
1985;90(3):391-398.
45. Vallecilla C, Khiabani RH, Trusty P et al. Exercise capacity in the
Bidirectional Glenn physiology: Coupling cardiac index, ventricular
function and oxygen extraction ratio.
J Biomech 2015;48(10):1997-2004.
46. Keizman E, Yarden ST, Mishali D et al. The bilateral bidirectional
Glenn operation as a risk factor prior to Fontan completion in complex
congenital heart disease patients. World J Pediatr Congenit Heart Surg
2019;10(2):174-181.
47. Kreutzer C, Kreutzer J, Kreutzer GO. Reflections on five decades of
the Fontan-Kreutzer procedure. Front Pediatr. 2013;1:45.
48. Vigano G, McMahon CJ, Walsh K et al. High-risk Fontan completion
patients achieve low perioperative risk and benefit from cavopulmonary
connection 7 years out. Eur J Cardiothorac Surg 2019;56(4):664-670.
49. Di Maria MV, Mulvahill M, Jaggers J, Ivy DD, Younoszai AK.
Predictive value of presuperior cavopulmonary anastomosis cardiac
catheterization at increased altitude. Congenit Heart Dis
2018;13(2):311-318.
50. Salavitabar A, Bradley EA, Chisolm JL et al. Implantable pulmonary
artery pressure monitoring device in patients with palliated congenital
heart disease: Technical considerations and procedural outcomes.
Catheter Cardiovasc Interv 2020;95(2):270-279.